Prognostic Value of Baseline [18F] Fluorodeoxyglucose Positron Emission Tomography and 99mTc-MDP Bone Scan in Progressing Metastatic Prostate Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-1357
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

18f-Fluorodeoxyglucose Positron-Emission Tomography-Computed Tomography to Diagnose Recurrent Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Radiomics Features of 18f-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer

2019English

Efficacy of 18f-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluating Lung Cancer Recurrence

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2013English

18f-Fluorodeoxyglucose and 18f-Flumazenil Positron Emission Tomography in Patients With Refractory Epilepsy

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

[18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Diagnosing Polymyositis/Dermatomyositis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Fluorodeoxyglucose-Positron Emission Tomography

English

Prosthetic Valve Endocarditis Diagnosed by 18f-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Mayo Clinic Proceedings
Medicine
2019English

Standardized Uptake Value of 18f-Fluorodeoxyglucose Positron Emission Tomography for Prediction of Tumor Recurrence in Breast Cancer Beyond Tumor Burden

Breast Cancer Research
Cancer ResearchOncology
2014English

18f-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography as a Screening Tool for Second Primary Cancers in Cancer Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy